Skip to main content
. 2013 Aug 6;1:e114. doi: 10.7717/peerj.114

Table 3. Quality of life outcomes.

Mean change in QOLIE-31 as reported in the Ben-Menachem et al. (2007) trial.

Placebo Lacosamide
200 mg
Lacosamide
400 mg
Lacosamide
600 mg
QOLIE-31 median change in overall score from baseline −1.3 points NR 2.7 points NR
Clinical Global Impression of Change (CGIC) 25% 35% 40% 38%

Notes.

An increase in score indicates an improvement in quality of life as measured by the score. QOLIE-31 = quality of life in epilepsy inventory.